Enis Aboalhasan
Sapir College(IL)
Publications by Year
Research Areas
Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Pancreatic function and diabetes, Pharmacology and Obesity Treatment, Heart Failure Treatment and Management
Most-Cited Works
- → Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis(2022)40 cited
- → Liraglutide versus semaglutide for weight reduction—a cost needed to treat analysis(2023)23 cited
- → Usefulness of Sodium-Glucose Cotransporter 2 Inhibitors for Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus(2021)14 cited
- → Dapagliflozin vs. sacubitril-valsartan for prevention of heart failure events in non-diabetic patients with reduced ejection fraction: a cost per outcome analysis(2020)12 cited
- → Dapagliflozin versus empagliflozin in patients with chronic kidney disease(2023)10 cited
- → Icosapent Ethyl for Primary Versus Secondary Prevention of Major Adverse Cardiovascular Events in Hypertriglyceridemia: Value for Money Analysis(2021)10 cited
- → Usefulness of Empagliflozin Versus Oral Semaglutide for Prevention of Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus(2022)5 cited
- → Dapagliflozin Versus Sacubitril–Valsartan to Improve Outcomes of Patients with Reduced Ejection Fraction and Diabetes Mellitus(2021)4 cited
- → Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis(2020)4 cited
- → Effect of Dapagliflozin Versus Empagliflozin on Cardiovascular Death in Patients with Heart Failure Across the Spectrum of Ejection Fraction: Cost per Outcome Analysis(2023)3 cited